Lack of change in the levels of liver and kidney cytochrome P-450 isozymes in p53 (+/–) knockout mice treated with N- butyl- N- (4-hydroxybutyl)nitrosamine

By Mori Y.   Koide A.   Fuwa K.   Wanibuchi H.   Fukushima S.  

Mutagenesis, Vol. 16, Iss. 5, 2001-09 ,pp. : 377-383

Oxford University Press

Access to resources Recommend Favorite

Chondrodysplasia of gene knockout mice for aggrecan and link protein: SPECIAL ISSUE ON PROTEOGLYCANS: GENETIC MANIPULATION IN INTACT ORGANISMS—ON THE ROAD TO FUNCTION

By Watanabe Hideto   Yamada Yoshihiko  

Glycoconjugate Journal, Vol. 19, Iss. 4-5, 2002-05 ,pp. : 269-273

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates

By Mankowski D. C.   Lawton M. P.   Ekins S.  

Xenobiotica, Vol. 30, Iss. 8, 2000-08 ,pp. : 745-754

Informa Healthcare

Access to resources Recommend Favorite

Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism

By Chitnis Shripad D.  

Xenobiotica, Vol. 43, Iss. 7, 2013-07 ,pp. : 641-649

Informa Healthcare

Access to resources Recommend Favorite

Mutagenesis Study of Asp-290 in Cytochrome P450 2B11 Using a Fusion Protein with Rat NADPH-Cytochrome P450 Reductase

By Harlow G.R.   Halpert J.R.  

Archives of Biochemistry and Biophysics, Vol. 326, Iss. 1, 1996-02 ,pp. : 85-92

Elsevier

Access to resources Recommend Favorite